Kedrion Biopharma Inc. expands the distribution network for Ryplazim, a plasma-derived human plasminogen indicated for treating patients with plasminogen deficiency type 1 (PLGD-1). This expansion ...

But, in a twist, the Commission will only announce projects inside the bloc. Applications for projects in third countries will have to wait, my colleagues Jakob Weizman and Koen Verhelst report in ...

The content on this site is intended for science and health care professionals. We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, ...